Integrative cancer therapies · 2026
Electroacupuncture Versus Auricular Acupressure Versus WaitliSt Control for Endocrine Therapy-Related Joint Pain in Patients With Breast Cancer (EASE): Study Protocol for a Pragmatic Multicenter Randomised Controlled Trial.
СтатьяПротокол клинического исследованияНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xue Jing, Lin Lisen, Wang Bin, Wang Miaozhou, Wang Hailong, Feng Xiumei, Yang Mingxiao, Yan Shiyan, Zhao Jiuda, Pan Zhanyu, Pan Yue, Chen Qianqian, Yang Li, Dong Xiao, Sun Sihan, Cai Lin, Wang Yaoran, Chen Qiaorui, Kong Fanming, Zhang Yunchao, Li Menghan, Wang Chaoran, Wei Jiachang, Ruan Zhanliang, Guo Yiting, Xing Qiming, Song Qian, Fan Xiaonong, Yang Sha, Wang Guanran, Zhao Fuxing, Pu Fahe, Li Qian, Huang Ying, Li Qi, Lv Hongcheng, Dong Jianchu, Wang Shu, Li Li
Аннотация
BackgroundThe incidence of breast cancer has been steadily increasing in recent years. Endocrine therapy, as a first-line treatment, is typically required for 5 to 10 years. However, joint pain is one of the most common adverse effects, affecting 50%-70% of patients and significantly compromising treatment adherence and quality of life. Current management strategies have limited efficacy. Electroacupuncture has been shown to alleviate joint pain intensity and improve related symptoms, but the need for frequent hospital visits imposes a logistical burden on patients and their families, which may reduce adherence and limit accessibility. Auricular acupressure offers a simple and safe alternative that provide sustained stimulation, and facilitates hospital-guided, home-based self-management between clinic visits. This trial aims to evaluate the effectiveness and safety of electroacupuncture and auricular acupressure versus waitlist control for endocrine therapy-related joint pain in patients with breast cancer.Methods and analysisThis multicentre, pragmatic, three-arm randomised controlled trial will enrol 200 eligible participants with breast cancer experiencing endocrine therapy-related joint pain. Participants will be randomised in a 2:2:1 ratio to receive electroacupuncture, auricular acupressure, or waitlist control. The primary outcome is the change from baseline to week 8 in the Brief Pain Inventory-Short Form (BPI-SF) worst pain score. Secondary outcomes include the BPI-SF pain severity and pain interference scores, the Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health scale, the Functional Assessment of Cancer Therapy-Endocrine Symptoms (FACT-ES), the EuroQol-5 Dimension 5-Level (EQ-5D-5L), the Quantitative Analgesic Questionnaire (QAQ), and the Credibility/Expectancy Questionnaire (CEQ). Intervention adherence, endocrine therapy usage, and adverse events will also be recorded. Analyses will follow the modified intention-to-treat principle. The trial will compare each active intervention with the waitlist control and assess whether auricular acupressure is non-inferior to electroacupuncture.Ethics and DisseminationThis study protocol has been approved by the ethics committees of the participating institutions. The trial results will be disseminated through peer-reviewed publications and conference presentations.